Madeline Moves, Inc. – Trademark Portfolio
Entity Type: 03
Madeline Moves, Inc. owns a portfolio of 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as M, MOVES, MOVES APP, MADELINE MOVES, and TIGHTER TOGETHER. Of these, 17 are registered. The portfolio spans 3 Nice Classification classes, led by Class 41 (Education & Entertainment) and Class 9 (Computers & Electronics). Headquartered in Greenville, SC.
5013B Old Bumcombe Rd
Greenville, SC 29617
Showing of trademarks Trademarks
Trademark Classifications
Madeline Moves, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Madeline Moves, Inc. have?
Madeline Moves, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 17 registered.
What trademark classes does Madeline Moves, Inc. file in?
Madeline Moves, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Madeline Moves, Inc.'s most well-known trademarks?
Madeline Moves, Inc.'s registered trademark portfolio includes well-known marks such as M, MOVES, MOVES APP, MADELINE MOVES, and TIGHTER TOGETHER. These are among 17 currently registered trademarks in the portfolio.
What is Madeline Moves, Inc.'s trademark registration success rate?
Madeline Moves, Inc. has a 100% trademark registration rate, with 17 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.